Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Biote
AddedFeb 19, 2024
UpdatedJun 18, 2026
Biote

Biote

Public

Biote, OOO: A leading provider of personalized hormone optimization and vehicle distribution since 1999.

HQ
Irving, TX, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Founded in 1999, Biote is a pioneering company specializing in personalized hormone optimization. The company's core mission is to enhance individual well-being by optimizing hormone levels, thereby improving overall health, energy, and vitality. Biote offers a range of services aimed at restoring and revitalizing hormones to support better health outcomes and relationships. Their market focus includes individuals seeking tailored hormone therapy solutions to address various health concerns.

Biote has garnered attention for its innovative approach to hormone optimization, attracting notable healthcare professionals and investors committed to advancing personalized medicine. The company has achieved significant milestones in the field of hormone therapy, contributing to improved patient outcomes and quality of life. Through its specialized services, Biote has made a substantial impact on the healthcare industry, positioning itself as a leader in precision medicine and personalized health solutions.

Biote - Quick Facts

When was Biote founded?

Biote was founded in 2012.

Where is Biote's headquarters located?

Biote's headquarters is located in Irving, TX, US.

When was Biote's last funding round?

Biote's most recent funding round was for $25.5M (USD) in January 2023.

How much has Biote raised to-date?

As of Jan 1, 2023, Biote has raised a total of $25.5M (USD).

How many employees does Biote have?

Biote has 186 employees as of Feb 5, 2024.

Biote - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Hormone Therapy
Tags
  • Healthtech
Unique IDs
  • ein: 851791125
  • secCik: 0001819253
  • ticker: BTMD
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325411Medicinal and Botanical Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 2833Medicinal Chemicals And Botanical Products
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 5 more industry codes
NAICS
  • 440000Retail Trade
SIC
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 5900Miscellaneous Retail
  • 6700Holding And Other Investment Offices